Key result
Plasma volume expansion restores altitude-depressed stroke volume during tilt testing.
Why the study?
Does plasma volume expansion restore the altitude-induced reduction in stroke volume during postural challenges in healthy lowlanders acclimatized to 3454 m?
Does plasma volume expansion restore the altitude-induced reduction in stroke volume during postural challenges in healthy lowlanders acclimatized to 3454 m?
This physiological study demonstrates that the reduction in resting stroke volume during high-altitude acclimatization is entirely explained by hypovolemia and reduced central blood volume rather than impaired myocardial contractility or hypoxic pulmonary vasoconstriction.
Answers are grounded in this paper and cite their sources.
Supports volume depletion rather than intrinsic cardiac dysfunction as the driver of altitude-related stroke volume decline; leaves open its clinical relevance in patients with cardiovascular disease.
During acute altitude exposure tachycardia increases cardiac output (Q) thus preserving systemic O2 delivery. Within days of acclimatization, however, Q normalizes following an unexplained reduction in stroke volume (SV). To investigate whether the altitude-mediated reduction in plasma volume (PV) and hence central blood volume (CBV) is the underlying mechanism we increased/decreased CBV by means of passive whole body head-down (HDT) and head-up (HUT) tilting in seven lowlanders at sea level (SL) and after 25/26 days of residence at 3454 m. Prior to the experiment on day 26, PV was normalized by infusions of a PV expander. Cardiovascular responses to whole body tilting were monitored by pulse contour analysis. After 25/26 days at 3454 m PV and blood volume decreased by 9 ± 4% and 6 ± 2%, respectively (P < 0.001 for both). SV was reduced compared to SL for each HUT angle (P < 0.0005). However, the expected increase in SV from HUT to HDT persisted and ended in the same plateau as at SL, albeit this was shifted 18 ± 20° toward HDT (P = 0.019). PV expansion restored SV to SL during HUT and to an ∼8% higher level during HDT (P = 0.003). The parallel increase in SV from HUT to HDT at altitude and SL to a similar plateau demonstrates an unchanged dependence of SV on CBV, indicating that the reduced SV during HUT was related to an attenuated CBV for a given tilt angle. Restoration of SV by PV expansion rules out a significant contribution of other mechanisms, supporting that resting SV at altitude becomes reduced due to a hypovolemia.
No takes yet. Share an insight, caveat, or question.
Siebenmann et al. (2013) studied Altitude-induced hypovolemia and stroke volume reduction (n=7). Altitude exposure (3454 m) followed by intravenous plasma volume expansion with isotonic Dextran solution vs. Sea level baseline (~500 m) and pre-expansion altitude state (day 25 at 3454 m) was evaluated on Stroke volume response to passive whole body head-up tilt (HUT) and head-down tilt (HDT) (p=<0.0005). Plasma volume expansion after 26 days at 3454 m restored stroke volume to sea level values during head-up tilt and increased it by ~8% during head-down tilt.
Synapse has enriched 10 related papers. Consider them for comparative context: